Dexcom reported Q4 results, with revenue up 8%, beating estimates. CEO looks forward to unlocking next wave of global access.

DexCom projects 2025 revenue of $4.6 billion, representing 14% growth. This forecast assumes strong demand for CGM systems, expanded reimbursement coverage, and a second-half launch of a 15-day G7 ...

Looking forward, DexCom's management has reiterated its fiscal year 2025 forecast, anticipating revenue growth of 14% with a ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

DexCom, Inc. DXCM is scheduled to release fourth-quarter 2024 results on Feb. 13, after the closing bell. In the last ...

The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the ...

The UAE has announced fuel prices for February, hiking the rates after two months of unchanged prices. The new rates will apply from February 1 and are as follows: Super 98 petrol will cost Dh2.74 ...

Shontel Brown want President Donald Trump’s administration to clarify the effects a new executive order that rescinds ... affect the efforts to lower drug prices that Biden’s order created.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In March 2024, the Food and Drug Administration cleared Dexcom’s Stelo as the first over-the ... Additionally, eating foods in a specific order—like eating the lettuce and tomato first ...